Last reviewed · How we verify
NCT05377866
Holo CTO Proctoring Study
trial testing Remote proctoring using HoloLens in Percutaneous Coronary Intervention in 10 participants. Completed in 31 January 2023.
31 December 2022
Quick facts
| Lead sponsor | Sorlandet Hospital HF |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 10 |
| Start date | 4 November 2021 |
| Primary completion | 31 December 2022 |
| Estimated completion | 31 January 2023 |
| Sites | 1 location across Norway |
Drugs / interventions tested
- Remote proctoring using HoloLens
Conditions studied
- Percutaneous Coronary Intervention — all drugs for Percutaneous Coronary Intervention →
- Chronic Total Occlusion of Coronary Artery — all drugs for Chronic Total Occlusion of Coronary Artery →
Sponsor
Sorlandet Hospital HF
Who can join
18 and older, any sex, with Percutaneous Coronary Intervention or Chronic Total Occlusion of Coronary Artery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Assess Microsoft HoloLens as an interactive communication device in remote proctoring, and enhancement of teamwork in complex CTO procedures
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05377866
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Percutaneous Coronary Intervention
Currently open trials in the same condition.
- NCT07231939 — Use of Flozins (Empagliflozin/Dapagliflozin) for Prevention of AKI · recruiting
- NCT07378163 — Study on the Preferences for PCI Implantation Devices Among Doctors and Patients · recruiting
- NCT07378137 — Comparing the Components of Composite Endpoints for Healthcare Providers and Patients · recruiting
- NCT06878729 — Antegrade Dissection and Re-entry Versus Retrograde Strategy in CTO PCI · NA · recruiting
- NCT07446023 — IVUS-FFR Accuracy for Coronary Stenosis · NA · recruiting
Other Sorlandet Hospital HF trials
Trials by the same sponsor.
- NCT06983639 — Randomized Trial Comparing Fecal Testing (FIT) to Colonoscopy for Post-polypectomy Surveillance · NA · recruiting
- NCT07205614 — The Good Pain Consultation in Endometriosis. · NA · not yet recruiting
- NCT07203469 — Where Wild Things Grow: Nature- and Activity-based Group Interventions for Neurodivergent Children and Youth · NA · recruiting
- NCT05926401 — Atrial Fibrillation Prior and Post Elective Cardioversion · unknown
- NCT06364878 — Non-invasive Diagnostics of Microbial Keratitis · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05377866 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sorlandet Hospital HF
- Last refreshed: 1 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05377866.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing